The HIV-associated tuberculosis epidemic—when will we act?
Year: 2010
Type: review
Source: The Lancet
Institutions: London School of Hygiene & Tropical Medicine, International Union Against Tuberculosis and Lung Disease, International Union Against Tuberculosis and Lung Disease, Médecins Sans Frontières, Médecins Sans Frontières, Médecins Sans Frontières, Médecins Sans Frontières, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Cape Town, Institute of Infectious Disease and Molecular Medicine, REDE-TB (Rede Brasileira de Pesquisa em Tuberculose), Treatment Action Group, MRC/UVRI & LSHTM Uganda Research Unit, Uganda Virus Research Institute, Stellenbosch University, Centers for Disease Control and Prevention
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: HIV-associated tuberculosis, tuberculosis prevention, early HIV diagnosis, antiretroviral therapy, infection control, isoniazid preventive therapy, cotrimoxazole prophylaxis, tuberculosis incidence, immune reconstitution, HIV transmission, directly observed therapy, sub-Saharan Africa, Southern Africa
Open Access status: closed
OpenAlex ID: W2104567479
